FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022505130> ?p ?o ?g. }

• W2022505130 endingPage "72" @default.
• W2022505130 startingPage "64" @default.
• W2022505130 abstract "Immunological responses are increasingly recognised as being important in the initiation and progression of myelodysplastic syndrome (MDS). Indeed, autoimmune diseases commonly occur in association with MDS, particularly in subtypes with a low risk of leukaemic transformation. This study showed for the first time that the numbers of CD3+ CD4+ IL-17 producing T cells (Th17) were markedly increased in low risk MDS compared with high risk MDS (P < 0·01). An inverse relationship between the numbers of Th17 cells and naturally occurring CD4+CD25high FoxP3+ regulatory T cells (Tregs) were also described. The Th17:Tregs ratio was significantly higher in low risk disease (P < 0·005) compared with high risk MDS and was correlated with increased bone marrow (BM) apoptosis (P < 0·01). Tregs from MDS patients suppressed interferon-γ (IFN-γ) secretion by effector CD4+ T cells but had no effect on interleukin (IL)-17 production. In addition, the serum levels of IL-7, IL-12, RANTES and IFN-γ are significantly elevated in low risk MDS, while inhibitory factors, such as IL-10 and soluble IL-2 receptor, are significantly higher in high risk disease. The ‘unfavourable’ Th17:Tregs ratio in low risk MDS may explain the higher risk of autoimmunity and the improved response to immune suppression in patients with low risk MDS compared to those with high risk disease." @default.
• W2022505130 created "2016-06-24" @default.
• W2022505130 creator A5001573915 @default.
• W2022505130 creator A5010690912 @default.
• W2022505130 creator A5032585809 @default.
• W2022505130 creator A5042602459 @default.
• W2022505130 creator A5045070181 @default.
• W2022505130 creator A5047517477 @default.
• W2022505130 creator A5048532379 @default.
• W2022505130 creator A5057414314 @default.
• W2022505130 creator A5057770837 @default.
• W2022505130 creator A5065601240 @default.
• W2022505130 creator A5072940837 @default.
• W2022505130 creator A5083310643 @default.
• W2022505130 date "2009-04-01" @default.
• W2022505130 modified "2023-10-15" @default.
• W2022505130 title "IL-17-producing CD4⁺T cells, pro-inflammatory cytokines and apoptosis are increased in low risk myelodysplastic syndrome" @default.
• W2022505130 cites W1527011538 @default.
• W2022505130 cites W1553271826 @default.
• W2022505130 cites W1967949472 @default.
• W2022505130 cites W1982243301 @default.
• W2022505130 cites W1985126564 @default.
• W2022505130 cites W1992750664 @default.
• W2022505130 cites W1995265726 @default.
• W2022505130 cites W2009489603 @default.
• W2022505130 cites W2013053106 @default.
• W2022505130 cites W2017299585 @default.
• W2022505130 cites W2019932788 @default.
• W2022505130 cites W2028623326 @default.
• W2022505130 cites W2034295333 @default.
• W2022505130 cites W2066935327 @default.
• W2022505130 cites W2082615180 @default.
• W2022505130 cites W2083377487 @default.
• W2022505130 cites W2096638244 @default.
• W2022505130 cites W2112866067 @default.
• W2022505130 cites W2114140047 @default.
• W2022505130 cites W2124023185 @default.
• W2022505130 cites W2135399946 @default.
• W2022505130 cites W2149982846 @default.
• W2022505130 cites W2155779547 @default.
• W2022505130 cites W2296225964 @default.
• W2022505130 cites W251630186 @default.
• W2022505130 cites W2776663677 @default.
• W2022505130 doi "https://doi.org/10.1111/j.1365-2141.2009.07593.x" @default.
• W2022505130 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19210506" @default.
• W2022505130 hasPublicationYear "2009" @default.
• W2022505130 type Work @default.
• W2022505130 sameAs 2022505130 @default.
• W2022505130 citedByCount "165" @default.
• W2022505130 countsByYear W20225051302012 @default.
• W2022505130 countsByYear W20225051302013 @default.
• W2022505130 countsByYear W20225051302014 @default.
• W2022505130 countsByYear W20225051302015 @default.
• W2022505130 countsByYear W20225051302016 @default.
• W2022505130 countsByYear W20225051302017 @default.
• W2022505130 countsByYear W20225051302018 @default.
• W2022505130 countsByYear W20225051302019 @default.
• W2022505130 countsByYear W20225051302020 @default.
• W2022505130 countsByYear W20225051302021 @default.
• W2022505130 countsByYear W20225051302022 @default.
• W2022505130 countsByYear W20225051302023 @default.
• W2022505130 crossrefType "journal-article" @default.
• W2022505130 hasAuthorship W2022505130A5001573915 @default.
• W2022505130 hasAuthorship W2022505130A5010690912 @default.
• W2022505130 hasAuthorship W2022505130A5032585809 @default.
• W2022505130 hasAuthorship W2022505130A5042602459 @default.
• W2022505130 hasAuthorship W2022505130A5045070181 @default.
• W2022505130 hasAuthorship W2022505130A5047517477 @default.
• W2022505130 hasAuthorship W2022505130A5048532379 @default.
• W2022505130 hasAuthorship W2022505130A5057414314 @default.
• W2022505130 hasAuthorship W2022505130A5057770837 @default.
• W2022505130 hasAuthorship W2022505130A5065601240 @default.
• W2022505130 hasAuthorship W2022505130A5072940837 @default.
• W2022505130 hasAuthorship W2022505130A5083310643 @default.
• W2022505130 hasBestOaLocation W20225051301 @default.
• W2022505130 hasConcept C126322002 @default.
• W2022505130 hasConcept C203014093 @default.
• W2022505130 hasConcept C2778690821 @default.
• W2022505130 hasConcept C2779727006 @default.
• W2022505130 hasConcept C2780007613 @default.
• W2022505130 hasConcept C2780130043 @default.
• W2022505130 hasConcept C2780817109 @default.
• W2022505130 hasConcept C502942594 @default.
• W2022505130 hasConcept C71924100 @default.
• W2022505130 hasConcept C8891405 @default.
• W2022505130 hasConceptScore W2022505130C126322002 @default.
• W2022505130 hasConceptScore W2022505130C203014093 @default.
• W2022505130 hasConceptScore W2022505130C2778690821 @default.
• W2022505130 hasConceptScore W2022505130C2779727006 @default.
• W2022505130 hasConceptScore W2022505130C2780007613 @default.
• W2022505130 hasConceptScore W2022505130C2780130043 @default.
• W2022505130 hasConceptScore W2022505130C2780817109 @default.
• W2022505130 hasConceptScore W2022505130C502942594 @default.
• W2022505130 hasConceptScore W2022505130C71924100 @default.
• W2022505130 hasConceptScore W2022505130C8891405 @default.
• W2022505130 hasIssue "1" @default.
• W2022505130 hasLocation W20225051301 @default.
• W2022505130 hasLocation W20225051302 @default.

• next